Clinical Characteristics and Outcome of Hospitalized Patients With Congestive Heart Failure
-
- Kawashiro Naomi
- Department of Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University
-
- Kasanuki Hiroshi
- Department of Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University
-
- Ogawa Hiroshi
- Department of Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University
-
- Matsuda Naoki
- Department of Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University
-
- Hagiwara Nobuhisa
- Department of Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University
書誌事項
- タイトル別名
-
- Clinical Characteristics and Outcome of Hospitalized Patients With Congestive Heart Failure Results of the HIJC-HF Registry
- Results of the HIJC-HF Registry
この論文をさがす
説明
Background Heart failure (HF) represents a major public health issue in an aging population. Although HF is a leading cause of morbidity and mortality in developed countries, the clinical features of HF in Japan remain unclear. Methods and Results This observational cohort study analyzed data from the Heart Institute of Japan - Department of Cardiology (HIJC)-HF Registry, which is based on a nationwide survey by the HIJC, Tokyo Women's Medical University and its affiliated hospitals. Of 3,578 consecutive patients (average age, 69.8 years; females 40.7%) hospitalized for HF between January 2001 and December 2002, 95.0% were followed up until the end of 2005 (median, 2.8 years). The 1- and 3-year mortality rates were 11.3% and 29.2%, respectively. Multivariate analysis revealed that advanced age (hazard ratio 1.71 [95% confidence interval 1.38-2.12]; p<0.001), symptomatic HF at hospital discharge (3.76 [2.30-6.17]; p<0.001), renal impairment (1.96 [1.50-2.57]; p=0.008), anemia (1.46 [1.18-1.80]; p=0.02) and low pulse pressure (2.88 [1.62-5.13]; p=0.0003) were significantly associated with total death. Conclusion Although the long-term mortality rate for Japanese patients with HF is lower than in other countries, several markers are modifiable. The data demonstrate that continued improvements in the treatment of Japanese patients with HF are still needed. (Circ J 2008; 72: 2015 - 2020)<br>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 72 (12), 2015-2020, 2008
一般社団法人 日本循環器学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205105804160
-
- NII論文ID
- 110006987357
-
- NII書誌ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- PubMed
- 18931450
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可